The Dr. Sol J. Barer Award for Vision, Innovation, and Leadership was established by the BioNJ Board of Trustees in March 2008 in an effort to recognize the outstanding research and business leaders who have made and continue to make significant contributions to the growth of the biosciences in New Jersey and around the world. The honoree is voted on by the BioNJ Board of Trustees from a recommendation based on nominations received by the Nominating Committee. The award is named for Sol J. Barer, Ph.D., who founded the biotechnology group at Celanese that was subsequently spun out to form Celgene, currently one of the world’s largest biotechnology companies.
Past award recipients have included Dr. Barer; Dr. Lisa Drakeman, former President and CEO of Genmab; John H. Johnson, President and CEO of Dendreon; John Crowley, Chairman and Chief Executive Officer of Amicus Therapeutics; Paul G. Thomas, Founder and CEO of Roka Bioscience; Francois Nader, M.D., President and CEO of NPS Pharmaceuticals Inc; and Stuart Peltz, Ph.D., CEO of PTC Therapeutics, Inc.
|2014||Stuart W. Peltz, Ph.D., CEO, PTC Therapeutics, Inc. Click here for video.|
|2013||Francois Nader, M.D., President & CEO, NPS Pharma. Click here for video.
|2012||Paul Thomas, Founder & CEO, Roka Bioscience. Click here for video.|
|2011||John Crowley, President & CEO, Amicus Therapeutics. Click here for video.|
|2010||John Johnson, President & CEO, Dendreon|
|2009||Lisa Drakeman, Ph.D., Former President & CEO, Genmab|
|2008||Dr. Sol. J. Barer, Former Chairman, Celgene Corporation|